U.S. lawmakers to hold hearing on J&J recall May 27

* House Committee to hold J&J hearing on May 27

* CEO asked to testify

NEW YORK, May 14 (BestGrowthStock) – U.S. lawmakers will hold a
hearing on Johnson & Johnson’s (JNJ.N: ) recall of Children’s
Tylenol and other over-the-counter medicines later this month,
and have asked the company’s CEO to testify.

The House Committee on Oversight and Government Reform will
hold a hearing on May 27, and has asked J&J Chief Executive
William Weldon to testify, according to the panel’s website.

The company recently recalled 40 widely used children’s
pain and allergy medications, saying some may have a higher
concentration of their active ingredients, while others may be
contaminated. J&J has had four recalls in the past year of
over-the-counter medicines.

U.S. Food and Drug Administration inspectors have said they
found thick dust, grime and contaminated ingredients at the J&J
plant that produces Children’s Tylenol and dozens of other
products. [ID:nN04255618]

J&J has called the manufacturing problems unacceptable and
vowed to fix them. The company has suspended production at the
Pennsylvania plant where the recalled children’s products are
made.

Stock Investing

(Reporting by Ritsuko Ando and Lewis Krauskopf; Editing by
Richard Chang)

U.S. lawmakers to hold hearing on J&J recall May 27